Eosinophilic Esophagitis: all 238 studies
Page 3 of 3. Open to participants first (52), then studies with results posted, then the rest; newest registration first within each.
- Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE)CompletedNCT01929824
- Morphological Markers of Gastroesophageal Reflux Disease (GERD)SuspendedNCT01921686
- Assessing Risk of Food Insecurity Within Households of Children With Food AllergyCompletedNCT01897506
- Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?CompletedNCT01865825
- Dietetic Versus Topical Steroids for Pediatric Eosinophilic EsophagitisCompletedNCT01846962Phase 4
- Sirolimus for Eosinophil-Associated Gastrointestinal DisordersTerminatedNCT01814059Phase 1
- Eosinophilic Gastrointestinal Disorders Patient RegistryWithdrawnNCT01779154
- Eosinophilic Esophagitis Treatment: Montelukast vs FluticasoneWithdrawnNCT01702701Phase 3
- Allergy Immunotherapy in the Management of Eosinophilic EsophagitisWithdrawnNCT01685034Not applicable
- Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis PatientsCompletedNCT01641913Phase 1
- Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic EsophagitisCompletedNCT01631591
- New Serological Markers for Eosinophilic EsophagitisStatus unknownNCT01624129
- A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021CompletedNCT01498497
- Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic EsophagitisWithdrawnNCT01479231Phase 1/2
- Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic EsophagitisCompletedNCT01386112Phase 1/2
- Registry for Eosinophilic Gastrointestinal Disorders (REGID)CompletedNCT01382563
- Eosinophilic Esophagitis DatabankCompletedNCT01323803
- Confocal Laser Endomicroscopy in Patients With Eosinophilic EsophagitisCompletedNCT01234376
- Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal DisordersTerminatedNCT01212016
- Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic EsophagitisCompletedNCT01170234
- Proof of Concept Study of OC000459 in Eosinophilic EsophagitisCompletedNCT01056783Phase 2
- Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease ModelCompletedNCT01040598Phase 1
- Routine Screening for Eosinophilic Esophagitis in Patients Presenting With DysphagiaStatus unknownNCT01028235
- Efficacy and Safety of QAX576 in Patients With Eosinophilic EsophagitisCompletedNCT01022970Phase 2
- A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic EsophagitisCompletedNCT01016223Phase 1
- Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity IndexStatus unknownNCT00939263
- Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and InflammationCompletedNCT00667524
- Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic EsophagitisCompletedNCT00523354Phase 2
- Trial of Montelukast in Eosinophilic EsophagitisCompletedNCT00511316Phase 1
- An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult PatientsCompletedNCT00274703Phase 2
- Budesonide for Eosinophilic EsophagitisCompletedNCT00271349Phase 2
- Data Bank for Eosinophilic DisordersCompletedNCT00267475
- A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic DisordersCompletedNCT00266578Phase 3
- Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic SyndromeCompletedNCT00266565Phase 1/2
- Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With DysphagiaCompletedNCT00256529
- Montelukast in the Treatment of Duodenal EosinophiliaCompletedNCT00148603Not applicable
- Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic EsophagitisCompletedNCT00123656Phase 2
- Omalizumab to Treat Eosinophilic GastroenteritisCompletedNCT00084097Phase 2